U.S. Point-Of-Care Influenza Diagnostics Market Size & Outlook

Name: U.S. Point-Of-Care Influenza Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The point-of-care influenza diagnostics market in the United States is expected to reach a projected revenue of US$ 195.7 million by 2033. A compound annual growth rate of 5.94% is expected of the United States point-of-care influenza diagnostics market from 2026 to 2033.

Clinical Diagnostics
- Point of Care (PoC) Diagnostics
  - Point-of-Care Influenza Diagnostics Market Outlook

U.S. point-of-care influenza diagnostics test type outlook (Revenue, USD million, 2021-2033)
- Rapid Antigen Tests (RIDT)
- Molecular Point-of-Care Tests
- Biosensor-Based Tests
- Others
U.S. point-of-care influenza diagnostics influenza strain outlook (Revenue, USD million, 2021-2033)
- Influenza A
- Influenza B
- Influenza A & B Combined Tests
U.S. point-of-care influenza diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Immunoassay-based
- Molecular Diagnostics
- Nanotechnology based Systems
- Others
U.S. point-of-care influenza diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Clinics
- Homecare Settings
- Others

U.S. Point-Of-Care Influenza Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!